Overview

A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension

Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
SAFETY EXTENSION STUDY TO THE CORE STUDY CVAH631C2301
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Hydrochlorothiazide
Valsartan